Clinical performance and utilization of 3 PD-L1 immunohistochemical assays

被引：0
|
作者：
Anderson, Steven M.
Horten, Bruce
McCune, Bryan
Paler, Ronald
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-663
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
663
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Analysis of companion diagnostic potentials for multifaceted PD-L1 assays
    Caldara, Jeni
    Krueger, Joseph S.
    Ergon, Elliott
    Kearney, Staci
    Vennapusa, Bharathi
    CANCER RESEARCH, 2019, 79 (13)
  • [42] PD-L1 Expression in Melanoma: A Quantitative Immunohistochemical Antibody Comparison
    Sunshine, Joel C.
    Nguyen, Peter L.
    Kaunitz, Genevieve J.
    Cottrell, Tricia R.
    Berry, Sneha
    Esandrio, Jessica
    Xu, Haiying
    Ogurtsova, Aleksandra
    Bleich, Karen B.
    Cornish, Toby C.
    Lipson, Evan J.
    Anders, Robert A.
    Taube, Janis M.
    CLINICAL CANCER RESEARCH, 2017, 23 (16) : 4938 - 4944
  • [43] PD-L1 immunohistochemical testing: A review with reference to cytology specimens
    Layfield, Lester J.
    Zhang, Tao
    Esebua, Magda
    DIAGNOSTIC CYTOPATHOLOGY, 2023, 51 (01) : 51 - 58
  • [44] PD-L1 expression in sarcomas: An immunohistochemical study and review of the literature
    Cunningham, Christopher R.
    Dodd, Leslie
    Esebua, Magda
    Layfield, Lester J.
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2021, 55
  • [45] PD-L1 status in Taiwanese lung adenocarcinoma patients: Comparison of PD-L1 immunohistochemical assays using antibody clones 22C3, SP142 and SP263 with clinicopathological correlation
    Yeh, Y-C.
    Lin, S-F.
    Chiu, C-H.
    Wu, Y-C.
    Hsieh, W-Y.
    Ho, H-L.
    Chou, T-Y.
    ANNALS OF ONCOLOGY, 2016, 27
  • [46] Establishment of analytical performance features of two immunohistochemistry assays for PD-L1 expression in lung cancer
    Zhang, Lei
    Begot, Claire
    McGee, Robert
    Anderson, Steven M.
    CANCER RESEARCH, 2018, 78 (13)
  • [47] PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD-L1 IHC Assay Comparison Project
    Hirsch, Fred R.
    McElhinny, Abigail
    Stanforth, Dave
    Ranger-Moore, James
    Jansson, Malinka
    Kulangara, Karina
    Richardson, William
    Towne, Penny
    Hanks, Debra
    Vennapusa, Bharathi
    Mistry, Amita
    Kalamegham, Rasika
    Averbuch, Steve
    Novotny, James
    Rubin, Eric
    Emancipator, Kenneth
    McCaffery, Ian
    Williams, J. Andrew
    Walker, Jill
    Longshore, John
    Tsao, Ming Sound
    Kerr, Keith M.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (02) : 208 - 222
  • [48] Biomarkers in cancer immunotherapy: analysis of clinical, histological and immunohistochemical factors associated with PD-L1 status
    Bellesoeur, A.
    Massard, C.
    Soria, J-C.
    ANNALS OF ONCOLOGY, 2016, 27
  • [49] Immunohistochemical comparison of three programmed death-ligand 1 (PD-L1) assays in triple-negative breast cancer
    Yoshikawa, Katsuhiro
    Ishida, Mitsuaki
    Yanai, Hirotsugu
    Tsuta, Koji
    Sekimoto, Mitsugu
    Sugie, Tomoharu
    PLOS ONE, 2021, 16 (09):
  • [50] p40/PD-L1 and TTF1/PD-L1 Immunohistochemical Double Staining Contributes to Intraindividual Variability Associated With PD-L1 Staining Interpretation in Lung Cancer Samples
    Campelos, Sofia
    Polonia, Antonio
    Caramelo, Ana
    Curado, Monica
    Eloy, Catarina
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2022, 30 (03) : 165 - 170
12345